Use of ondansetron and other antiemetics in the management of toxic acetaminophen ingestions

Journal of Toxicology - Clinical Toxicology

Volumn 36, Issue 1-2, 1998, Pages 19-25

  Scharman, Elizabeth J ^a  

^a West Virginia Poison Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIEMETIC AGENT; METOCLOPRAMIDE; ONDANSETRON; PARACETAMOL; PROCHLORPERAZINE; PROMETHAZINE; TRIMETHOBENZAMIDE;

ADOLESCENT; ADULT; ANTIEMETIC ACTIVITY; ARTICLE; DRUG COST; DRUG EFFICACY; DRUG INTOXICATION; DRUG TOXICITY; FEMALE; HEALTH CARE COST; HUMAN; INGESTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POISON CENTER; RETROSPECTIVE STUDY; UNITED STATES; VOMITING;

EID: 0031901081     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659809162578     Document Type: Article

References (33)

1. Tobias JD, Gregory DF, Deshpande JK. Ondansetron to prevent emesis following N-acetylcysteine for acetaminophen intoxication. Pediatr Emerg Care 1992;8:345-346.
2. Reed MD, Marx CM. Ondansetron for treating nausea and vomiting in the poisoned patient. Ann Pharmacother 1994;28:331-333.
3. Clark RF, Chen R, Williams SR, Johnson CL, Harchelroad F. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning. J Toxicol Clin Toxicol 1996;34:163-167.
4. 3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 1990;322:816-821.
5. Hainsworth J, Harvey W, Pendergrass K, et al. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. J Clin Oncol 1991;9:721-728.
6. Markham A, Sorkin EM. Ondansetronm. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. Drugs 1993;45: 931-952.
7. Rangell MS, ed. Drug Topics Red Book. Montvale, NJ: Medical Economics, 1996.
8. Litovitz TL, Felberg L, White S, Klein-Schwartz W. 1995 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1996;14:487-537.
9. Rumack BH, Peterson RC, Koch GG, Amara IA. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 1981;141:380-385.
10. Smith T. Differences between general practices in hospital admission rates for self-inflicted injury and self-poisoning: Influence of socioeconomic factors. Br J Gen Pract 1995;45:458-462.
11. Kerfoot M, Dyer E, Harrington V, Woodham A, Harrington R. Correlates and short-term course of self-poisoning in adolescents. Br J Psychiatry 1996;168:38-42.
12. Gilbertson RJ, Harris E, Pandey SK, Kelly P, Myers W. Paracetamol use, availability, and knowledge of toxicity among British and American adolescents. Arch Dis Child 1996;75:194-198.
13. Hawton K, Ware C, Mistry H, et al. Why patients choose paracetamol for self poisoning and their knowledge of its dangers. BMJ 1995;310:164.
14. Bryson JC. Clinical safety of ondansetron. Semin Oncol 1992;19:26-32.
15. Finn AL. Toxicity and side effects of ondansetron. Semin Oncol 1992;19:53-60.
16. Garcia-del-Muro X, Cardenal F, Ferrer P. Extra-pyramidal reaction associated with ondansetron. Eur J Cancer 1993;29A:288.
17. Halperin JR, Murphy B. Extrapyramidal reaction to ondansetron. Cancer 1992;69:1275.
18. Dobrow RB, Coppock MA, Hosenpud JR. Extra-pyramidal reaction caused by ondansetron. J Clin Oncol 1991;9:1921.
19. Kossey JL, Kwok KK. Anaphylactoid reactions associated with ondansetron. Ann Pharmacother 1994;28:1029-1030.
20. McEvoy GK, Litvak K, Welsh OH, et al. American Hospital Formulary Service Drug Information. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1996.
21. Miller LF, Rumack BH. Clinical safety of high oral doses of acetylcysteine. Semin Oncol 1983:10:76-85.
22. Rosencrance JG, Scharman EJ. Anaphylactoid reaction to oral N-acetylcysteine: A case report. Vet Hum Toxicol 1993;35:357.
23. Sunman W, Hughes AD, Sever PS. Anaphylactoid response to intravenous acetylcysteine. Lancet 1992; 339:1231-1232.
24. Chan TY, Critchley JA. Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (acetaminophen) poisoning. Hum Exp Toxicol 1994;13:542-544.
25. Bailey B, McGuigan M. Management of allergoid and anaphylactoid reactions to IV N-acetylcysteine (NAC). J Toxicol Clin Toxicol 1996;34:585-586.
26. Bonfiglio MF, Traeger SM, Hulisz DT, Martin BR. Anaphylactoid reaction to intravenous acetylcysteine associated with electrocardiographic abnormalities. Ann Pharmacother 1992;26:22-25.
27. Mant TG, Tempowski JH, Volans GN, Talbot JC. Adverse reactions to acetylcysteine and effects of overdose. Br Med J Clin Res Ed 1984;289:217-219.
28. Lewis RK, Paloucek FP. Assessment and treatment of acetaminophen overdose. Clin Pharm 1991;10: 765-774.
29. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: A 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991;10:1058-1063.
30. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial. BMJ 1991;303:1026-1029.
31. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988;319:1557-1562.
32. Brown SG, Prentice DA. Ondansetron in the treatment of theophylline overdose. Med J Aust 1992;156:512.
33. Sage TA, Jones WN, Clark RF. Ondansetron in the treatment of intractable nausea associated with theophylline toxicity. Ann Pharmacother 1993;27: 584-585.